COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 2 for:    generx
Previous Study | Return to List | Next Study

Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia (AFFIRM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02928094
Recruitment Status : Not yet recruiting
First Posted : October 10, 2016
Last Update Posted : July 10, 2019
Huapont Life Sciences
Information provided by (Responsible Party):
Angionetics Inc.